We also found that the highest mean values of expression levels for all these biomarkers (SRC, ARNT, TBP, and SNAI2) belonged to the late-stage serous ovarian carcinoma group, with clear increasing trends from the serous BOT group to the late-stage group, and the calculated mean values of the relevant biomarkers were statistically significant (Figure 4B). The gene discussed is SNAI2; the disease is ovarian serous carcinoma.